Harriet Kluger, MD
Harvey and Kate Cushing Professor of Medicine (Oncology) and of DermatologyCards
About
Research
Overview
Medical Research Interests
Clinical Care
Overview
Dr. Kluger is a medical oncologist who sees patients with melanoma and renal cell carcinoma. Her research interests focus on developing new drug regimens and biomarkers predictive of response to therapies in melanoma and renal cell carcinoma. She participates in a number of clinical trials studying new agents for the treatment of these diseases, both targeting the immune system and the cancer cell. She runs an active research laboratory that studies tumor and immune cells from patients treated with novel therapies to determine mechanisms of resistance to therapy and mediators of toxicity from immune checkpoint inhibitors. The laboratory also conducts pre-clinical studies to improve treatment regimens for patients with melanoma, renal cell carcinoma or brain metastasis.
Clinical Specialties
Fact Sheets
Merkel Cell Carcinoma (MCC)
Learn More on Yale MedicineMetastatic Cancer
Learn More on Yale MedicineMelanoma
Learn More on Yale MedicineSkin Cancer
Learn More on Yale Medicine
Yale Medicine News
News & Links
News
- February 26, 2025
Celebrating Yale Cancer Center Faculty, Research Scientists
- January 01, 2025Source: AACR Cancer Progress Report
Jennifer Ficko: Thriving Thanks to a Melanoma Clinical Trial
- December 31, 2024
Accolades, Awards & Honors
- November 28, 2024
Unexpected Findings in Study of T Cells, Considered Front-line Fighters Against Advanced Melanoma
Get In Touch
Contacts
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
Events
School Only Clara Abraham, MD - Stefania Nicoli, PhD
School Only Speakers to be announced.
School Only Speakers to be announced.